ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE to reassess Kyowa Kirin’s Poteligeo pharmatimes
June 16, 2021The National Institute for Health and Care Excellence (NICE) will reassess Kyowa Kirin’s rare blood cancer treatment Poteligeo after upholding an appeal launched by the companies and various charities.
Pharma Sources Insight January 2025
